NCT00005870View on ClinicalTrials.gov

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

PHASE3UnknownINTERVENTIONAL
Timeline

Start Date

March 31, 1999

Conditions
Pancreatic Cancer
Interventions
DRUG

fluorouracil

DRUG

gemcitabine hydrochloride

DRUG

mitomycin C

DRUG

rubitecan

Trial Locations (2)

94583

SuperGen, Incorporated, San Ramon

14263-0001

Roswell Park Cancer Institute, Buffalo

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY